Suppressive effects of Clerodendrum volubile P Beauv. [Labiatae] methanolic extract and its fractions on type 2 diabetes and its complications

Frontiers in Pharmacology

Volumn 9, Issue FEB, 2018, Pages

  Erukainure, Ochuko L ^a,b,c   Hafizur, Rahman M ^b   Kabir, Nurul ^d   Choudhary, M Iqbal ^b   Atolani, Olubunmi ^e,f   Banerjee, Priyanka ^e   Preissner, Robert ^e   Chukwuma, Chika I ^g,h   Muhammad, Aliyu ^b,i   Amonsou, Eric O ^g   Islam, Md Shahidul ^c  

^a Federal Institute of Industrial Research Oshodi (FIIRO)   (Nigeria)

^b UNIVERSITY OF KARACHI   (Pakistan)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d UNIVERSITY OF MALAYA   (Malaysia)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY OF ILORIN   (Nigeria)

^g DURBAN UNIVERSITY OF TECHNOLOGY   (South Africa)

^h UNIVERSITY OF THE FREE STATE   (South Africa)

ⁱ AHMADU BELLO UNIVERSITY   (Nigeria)

Author keywords

Biochanin; Clerodendrum volubile; Immunohistochemistry; Type 2 diabetes and 5,7,4' trimethoxykaempferol

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA GLUCOSIDASE; ASPARTATE AMINOTRANSFERASE; BIOCHANIN A; BUTANOL; CALCIUM ION; CHOLESTEROL; CLERODENDRUM VOLUBILE EXTRACT; CYTOCHROME P450 1A2; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DICHLOROMETHANE; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; INSULIN; KAEMPFEROL DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHANOL; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; AQUEOUS SOLUTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CALCIUM BLOOD LEVEL; CELL FUNCTION; CELLULAR DISTRIBUTION; CHOLESTEROL BLOOD LEVEL; CLERODENDRUM; CLERODENDRUM VOLUBILE; COMPUTER MODEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; ENZYME INHIBITION; ENZYME INHIBITION ASSAY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; LIPID ANALYSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION REDUCTION REACTION; PANCREAS ISLET BETA CELL; RAT; TOXICITY TESTING; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 85041827691     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2018.00008     Document Type: Article

References (73)

1. Abuissa, H., Jones, P. G., Marso, S. P., and O'Keefe, J. H. (2005). Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes. J. Am. Coll. Cardiol. 46, 821-826. doi: 10.1016/j.jacc.2005.05.051
2. Adefegha, S. A., and Oboh, G. (2016). Antioxidant and inhibitory properties of Clerodendrum volubile leaf extracts on key enzymes relevant to non-insulin dependent diabetes mellitus and hypertension. J. Taibah Univ. Sci. 10, 521-533. doi: 10.1016/j.jtusci.2015.10.008
3. Ademiluyi, A. O., and Oboh, G. (2012). Phenolic-rich extracts from selected tropical underutilized legumes inhibit α-amylase, α-glucosidase, and angiotensin I converting enzyme in vitro. J. Basic Clin. Physiol. Pharmacol. 23, 17-25. doi: 10.1515/jbcpp-2011-0005
4. Adiels, M., Olofsson, S.-O., Taskinen, M.-R., and Borén, J. (2008). Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 28, 1225-1236. doi: 10.1161/ATVBAHA.107.160192
5. Aslan, M., Thornley-Brown, D., and Freeman, B. A. (2000). Reactive species in sickle cell disease. Ann. N. Y. Acad. Sci. 899, 375-391. doi: 10.1111/j.1749-6632.2000.tb06201.x
6. Banerjee, P., Erehman, J., Gohlke, B.-O., Wilhelm, T., Preissner, R., and Dunkel, M. (2014). Super Natural II-a database of natural products. Nucleic Acids Res. 43, D935-D939. doi: 10.1093/nar/gku886
7. Burkill, H. M. (1985). The Useful Plants of West Tropical Africa, 2nd Edn, Vol. 1. London: Kew, Royal Botanic Gardens
8. Cerf, M. E. (2013). Beta cell dysfunction and insulin resistance. Front. Endocrinol. 4:37. doi: 10.3389/fendo.2013.00037
9. Chance, B., and Maehly, A. (1955). Assay of catalases and peroxidases. Methods Enzymol. 2, 764-775. doi: 10.1016/S0076-6879(55)02300-8
10. Chikezie, P., Ojiako, O., and Nwufo, K. (2015). Overview of anti-diabetic medicinal plants: the Nigerian research experience. J. Diabetes Metab. 6:546. doi: 10.4172/2155-6156.1000546
11. Chowdhury, P., and Soulsby, M. (2002). Lipid peroxidation in rat brain is increased by simulated weightlessness and decreased by a soy-protein diet. Ann. Clin. Lab. Sci. 32, 188-192
12. Constantino, M. I., Molyneaux, L., Limacher-Gisler, F., Al-Saeed, A., Luo, C., Wu, T., et al. (2013). Long-term complications and mortality in young-onset diabetes. Diabetes Care 36, 3863-3869. doi: 10.2337/dc12-2455
13. Daina, A., Michielin, O., and Zoete, V. (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7:42717. doi: 10.1038/srep42717
14. Drwal, M. N., Banerjee, P., Dunkel, M., Wettig, M. R., and Preissner, R. (2014). ProTox: a web server for the in silico prediction of rodent oral toxicity. Nucleic Acids Res. 42, W53-W58. doi: 10.1093/nar/gku401
15. Du, X., Bai, Y., Liang, H., Wang, Z., Zhao, Y., Zhang, Q., et al. (2006). Solvent effect in 1H NMR spectra of 3'-hydroxy-4'-methoxy isoflavonoids from Astragalus membranaceus var. mongholicus. Magn. Reson. Chem. 44, 708-712. doi: 10.1002/mrc.1806
16. Echeverría, J., Opazo, J., Mendoza, L., Urzúa, A., and Wilkens, M. (2017). Structure-activity and lipophilicity relationships of selected antibacterial natural flavones and flavanones of Chilean flora. Molecules 22:608. doi: 10.3390/molecules22040608
17. Ellman, G. L. (1959). Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82, 70-77. doi: 10.1016/0003-9861(59)90090-6
18. Erukainure, O. L., Ebuehi, O. A., Adeboyejo, F. O., Okafor, E. N., Muhammad, A., and Elemo, G. N. (2013). Fiber-enriched biscuit enhances insulin secretion, modulates β-cell function, improves insulin sensitivity, and attenuates hyperlipidemia in diabetic rats. PharmaNutrition 1, 58-64. doi: 10.1016/j.phanu.2013.02.001
19. Erukainure, O. L., Ebuehi, O. A., Adeboyejo, F. O., Oladunmoye, O. O., Aliyu, M., Obode, O. C., et al. (2015). Short-term feeding of fibre-enriched biscuits: protective effect against hepatotoxicity in diabetic rats. Biochem. Res. Int. 2015:868937. doi: 10.1155/2015/868937
20. Erukainure, O. L., Ebuehi, O. A., Choudhary, I. M., Adhikari, A., Hafizur, R. M., Perveen, S., et al. (2014). Iridoid glycoside from the leaves of Clerodendrum volubile beauv. shows potent antioxidant activity against oxidative stress in rat brain and hepatic tissues. J. Diet. Suppl. 11, 19-29. doi: 10.3109/19390211.2013.859213
21. Erukainure, O. L., Hafizur, R. M., Choudhary, M. I., Adhikari, A., Mesaik, A. M., Atolani, O., et al. (2017a). Anti-diabetic effect of the ethyl acetate fraction of Clerodendrum volubile: protocatechuic acid suppresses phagocytic oxidative burst and modulates inflammatory cytokines. Biomed. Pharmacother. 86, 307-315. doi: 10.1016/j.biopha.2016.12.035
22. Erukainure, O. L., Mesaik, A. M., Muhammad, A., Chukwuma, C. I., Manhas, N., Singh, P., et al. (2016a). Flowers of Clerodendrum volubile exacerbate immunomodulation by suppressing phagocytic oxidative burst and modulation of COX-2 activity. Biomed. Pharmacother. 83, 1478-1484. doi: 10.1016/j.biopha.2016.09.002
23. Erukainure, O. L., Mesaik, M. A., Atolani, O., Muhammad, A., Chukwuma, C. I., and Islam, M. S. (2017b). Pectolinarigenin from the leaves of Clerodendrum volubile shows potent immunomodulatory activity by inhibiting T-cell proliferation and modulating respiratory oxidative burst in phagocytes. Biomed. Pharmacother. 93, 529-535. doi: 10.1016/j.biopha.2017.06.060
24. Erukainure, O. L., Zaruwa, M. Z., Choudhary, M. I., Naqvi, S. A., Ashraf, N., Hafizur, R. M., et al. (2016b). Dietary fatty acids from leaves of Clerodendrum volubile induce cell cycle arrest, downregulate matrix metalloproteinase-9 expression, and modulate redox status in human breast cancer. Nutr. Cancer 68, 634-645. doi: 10.1080/01635581.2016.1156714
25. Erukainure, O. L., Zaruwa, M. Z., Mesaik, A. M., Muhammad, A., Adoga, J. O., Ogunyemi, I. O., et al. (2017c). Suppression of phagocytic oxidative burst, cytotoxic effect, and computational prediction of oral toxicity of dietary fatty acids of Clerodendrum volubile stem. Comp. Clin. Pathol. 26, 663-671. doi: 10.1007/s00580-017-2438-y
26. Fokialakis, N., Alexi, X., Aligiannis, N., Siriani, D., Meligova, A. K., Pratsinis, H., et al. (2012). Ester and carbamate ester derivatives of Biochanin A: synthesis and in vitro evaluation of estrogenic and antiproliferative activities. Bioorg. Med. Chem. 20, 2962-2970. doi: 10.1016/j.bmc.2012.03.012
27. Friedewald, W. T., Levy, R. I., and Fredrickson, D. S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499-502
28. Godoy-Matos, A. F. (2014). The role of glucagon on type 2 diabetes at a glance. Diabetol. Metab. Syndr. 6:91. doi: 10.1186/1758-5996-6-91
29. Golay, A., and Ybarra, J. (2005). Link between obesity and type 2 diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 19, 649-663. doi: 10.1016/j.beem.2005.07.010
30. Grossman, A., and Grossman, E. (2017). Blood pressure control in type 2 diabetic patients. Cardiovasc. Diabetol. 16:3. doi: 10.1186/s12933-016-0485-3
31. Guerrero, L., Castillo, J., Quiñones, M., Garcia-Vallvé, S., Arola, L., Pujadas, G., et al. (2012). Inhibition of angiotensin-converting enzyme activity by flavonoids: structure-activity relationship studies. PLOS ONE 7:e49493. doi: 10.1371/journal.pone.0049493
32. Hafizur, R. M., Kabir, N., and Chishti, S. (2011). Modulation of pancreatic β-cells in neonatally streptozotocin-induced type 2 diabetic rats by the ethanolic extract of Momordica charantia fruit pulp. Nat. Prod. Res. 25, 353-367. doi: 10.1080/14786411003766904
33. Hafizur, R. M., Kabir, N., and Chishti, S. (2012). Asparagus officinalis extract controls blood glucose by improving insulin secretion and β-cell function in streptozotocin-induced type 2 diabetic rats. Br. J. Nutr. 108, 1586-1595. doi: 10.1017/S0007114511007148
34. Hafizur, R. M., Momin, S., and Fatima, N. (2017). Prevention of advanced glycation end-products formation in diabetic rats through beta-cell modulation by Aegle marmelos. BMC Complement. Altern. Med. 17:227. doi: 10.1186/s12906-017-1743-y
35. International Diabetes Federation [IDF] (2015). IDF Diabetes Atlas. Available at: http://www.diabetesatlas.org [accessed July 8, 2016]
36. Kakkar, P., Das, B., and Viswanathan, P. (1984). A modified spectrophotometric assay of superoxide dismutase. Indian J. Biochem. Biophys. 21, 130-132
37. Kanias, T., and Acker, J. P. (2010). Biopreservation of red blood cells-the struggle with hemoglobin oxidation. FEBS J. 277, 343-356. doi: 10.1111/j.1742-4658.2009.07472.x
38. Kaplan, N. M. (1987). Treating hypertension in the diabetic patient. Clin. Diabetes 5, 25-34
39. Kim, H. J., Yum, K. S., Sung, J.-H., Rhie, D.-J., Kim, M.-J., Hahn, S. J., et al. (2004). Epigallocatechin-3-gallate increases intracellular [Ca2+] in U87 cells mainly by influx of extracellular Ca2+ and partly by release of intracellular stores. Naunyn Schmiedebergs Arch. Pharmacol. 369, 260-267
40. Kitamura, M., Okuyama, M., Tanzawa, F., Mori, H., Kitago, Y., Watanabe, N., et al. (2008). Structural and functional analysis of a glycoside hydrolase family 97 enzyme from Bacteroides thetaiotaomicron. J. Biol. Chem. 283, 36328-36337. doi: 10.1074/jbc.M806115200
41. Kumar, S., and Pandey, A. K. (2013). Chemistry and biological activities of flavonoids: an overview. Sci. World J. 2013:162750. doi: 10.1155/2013/162750
42. Loizzo, M. R., Said, A., Tundis, R., Rashed, K., Statti, G. A., Hufner, A., et al. (2007). Inhibition of angiotensin converting enzyme (ACE) by flavonoids isolated from Ailanthus excelsa (Roxb) (Simaroubaceae). Phytother. Res. 21, 32-36. doi: 10.1002/ptr.2008
43. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275
44. Monzillo, L. U., and Hamdy, O. (2003). Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr. Rev. 61, 397-412. doi: 10.1301/nr.2003.dec.397-412
45. Noor, F., Rahman, H. M., Abdul, H., Shakil, A., Maliha, N., and Nurul, K. (2017). Ellagic acid in Emblica officinalis exerts anti-diabetic activity through the action on β-cells of pancreas. Eur. J. Nutr. 56, 591-601. doi: 10.1007/s00394-015-1103-y
46. Oboh, G., and Ademosun, A. O. (2011). Shaddock peels (Citrus maxima) phenolic extracts inhibit α-amylase, α-glucosidase and angiotensin I-converting enzyme activities: a nutraceutical approach to diabetes management. Diabetes Metab. Syndr. 5, 148-152. doi: 10.1016/j.dsx.2012.02.008
47. Oboh, G., Akinyemi, A. J., and Ademiluyi, A. O. (2013). Inhibitory effect of phenolic extract from garlic on angiotensin-1 converting enzyme and cisplatin induced lipid peroxidation-in vitro. Int. J. Biomed. Sci. 9, 98-106
48. Oboh, G., Olasehinde, T. A., and Ademosun, A. O. (2017). Inhibition of enzymes linked to Type-2 diabetes and hypertension by essential oils from peels of orange and lemon. Int. J. Food Prop. 20, S586-S594. doi: 10.1080/10942912.2017.1303709
49. Ondieki, G., Nyagblordzro, M., Kikete, S., Liang, R., Wang, L., and He, X. (2017). Cytochrome P450 and P-glycoprotein-mediated interactions involving African herbs indicated for common noncommunicable diseases. Evid. Based Complement. Altern. Med. 2017:2582463. doi: 10.1155/2017/2582463
50. Patel, D., Prasad, S., Kumar, R., and Hemalatha, S. (2012). An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac. J. Trop. Biomed. 2, 320-330. doi: 10.1016/S2221-1691(12)60032-X
51. Pi, J., Zhang, Q., Fu, J., Woods, C. G., Hou, Y., Corkey, B. E., et al. (2010). ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. Toxicol. Appl. Pharmacol. 244, 77-83. doi: 10.1016/j.taap.2009.05.025
52. Pittas, A. G., Lau, J., Hu, F. B., and Dawson-Hughes, B. (2007). The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 92, 2017-2029. doi: 10.1210/jc.2007-0298
53. Prentki, M., and Nolan, C. J. (2006). Islet β cell failure in type 2 diabetes. J. Clin. Invest. 116, 1802-1812. doi: 10.1172/JCI29103
54. Ramos-Nino, M. E., and Blumen, S. R. (2009). Benefits of ACE inhibitors in diabetes. Clin. Med. Ther. 1, 1041-1051. doi: 10.4137/CMT.S2027
55. Ramsay, K. S. T., Wafo, P., Ali, Z., Khan, A., Oluyemisi, O. O., Marasini, B. P., et al. (2012). Chemical constituents of Stereospermum acuminatissimum and their urease and α-chymotrypsin inhibitions. Fitoterapia 83, 204-208. doi: 10.1016/j.fitote.2011.10.014
56. Robertson, R. P., and Harmon, J. S. (2007). Pancreatic islet β-cell and oxidative stress: the importance of glutathione peroxidase. FEBS Lett. 581, 3743-3748. doi: 10.1016/j.febslet.2007.03.087
57. Rorsman, P., Braun, M., and Zhang, Q. (2012). Regulation of calcium in pancreatic α-and β-cells in health and disease. Cell Calcium 51, 300-308. doi: 10.1016/j.ceca.2011.11.006
58. Saeed, N., Khan, M. R., and Shabbir, M. (2012). Antioxidant activity, total phenolic and total flavonoid contents of whole plant extracts Torilis leptophylla L. BMC Complement. Altern. Med. 12:221. doi: 10.1186/1472-6882-12-221
59. Saponara, S., Sgaragli, G., and Fusi, F. (2008). Quercetin antagonism of Bay K 8644 effects on rat tail artery L-type Ca2+ channels. Eur. J. Pharmacol. 598, 75-80. doi: 10.1016/j.ejphar.2008.08.016
60. Scholz, E. P., Zitron, E., Katus, H. A., and Karle, C. A. (2010). Cardiovascular ion channels as a molecular target of flavonoids. Cardiovasc. Ther. 28, e46-e52. doi: 10.1111/j.1755-5922.2010.00212.x
61. Shafaei, A., Sultan Khan, M. S., Fa Aisha, A., Abdul Majid, A. M. S., Hamdan, M. R., Mordi, M. N., et al. (2016). Flavonoids-rich Orthosiphon stamineus extract as new candidate for angiotensin I-converting enzyme inhibition: a molecular docking study. Molecules 21:1500. doi: 10.3390/molecules21111500
62. Shukla, A., Priyadarshi, S., and Qamar, I. (2012). Involvement of calcium and vitamin C in Type 2 diabetes. IOSR J. Pharm. 2, 9-20. doi: 10.9790/3013-0210920
63. Spector, A. A., and Kim, H.-Y. (2015). Cytochrome P 450 epoxygenase pathway of polyunsaturated fatty acid metabolism. Biochim. Biophys. Acta 1851, 356-365. doi: 10.1016/j.bbalip.2014.07.020
64. Stumvoll, M., Mitrakou, A., Pimenta, W., Jenssen, T., Yki-Järvinen, H., Van Haeften, T., et al. (2000). Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23, 295-301. doi: 10.2337/diacare.23.3.295
65. Sun, H., Li, Y., Zhang, X., Lei, Y., Ding, W., Zhao, X., et al. (2015). Synthesis, α-glucosidase inhibitory and molecular docking studies of prenylated and geranylated flavones, isoflavones and chalcones. Bioorg. Med. Chem. Lett. 25, 4567-4571. doi: 10.1016/j.bmcl.2015.08.059
66. Tiwari, B. K., Pandey, K. B., Abidi, A., and Rizvi, S. I. (2013). Markers of oxidative stress during diabetes mellitus. J. Biomark. 2013:378790. doi: 10.1155/2013/378790
67. Tuck, M. L., Bounoua, F., Eslami, P., Nyby, M. D., Eggena, P., and Corry, D. B. (2004). Insulin stimulates endogenous angiotensin II production via a mitogen-activated protein kinase pathway in vascular smooth muscle cells. J. Hypertens. 22, 1779-1785. doi: 10.1097/00004872-200409000-00023
68. Urry, E., Jetter, A., and Landolt, H.-P. (2016). Assessment of CYP1A2 enzyme activity in relation to type-2 diabetes and habitual caffeine intake. Nutr. Metab. 13:66. doi: 10.1186/s12986-016-0126-6
69. Vijayaraghavan, K. (2010). Treatment of dyslipidemia in patients with type 2 diabetes. Lipids Health Dis. 9:144. doi: 10.1186/1476-511X-9-144
70. Vinayagam, R., and Xu, B. (2015). Antidiabetic properties of dietary flavonoids: a cellular mechanism review. Nutr. Metab. 12:60. doi: 10.1186/s12986-015-0057-7
71. Vozarova, B., Stefan, N., Lindsay, R. S., Saremi, A., Pratley, R. E., Bogardus, C., et al. (2002). High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51, 1889-1895. doi: 10.2337/diabetes.51.6.1889
72. WHO (2016). Global Report on Diabetes. Geneva: World Health Organization
73. Yeckel, C. W., Weiss, R., Dziura, J., Taksali, S. E., Dufour, S., Burgert, T. S., et al. (2004). Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J. Clin. Endocrinol. Metab. 89, 1096-1101. doi: 10.1210/jc.2003-031503